Outset Medical (OM) Return on Equity (2020 - 2025)
Outset Medical (OM) has disclosed Return on Equity for 6 consecutive years, with 0.61% as the latest value for Q4 2025.
- On a quarterly basis, Return on Equity rose 282.0% to 0.61% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.61%, a 282.0% increase, with the full-year FY2025 number at 1.06%, up 65.0% from a year prior.
- Return on Equity was 0.61% for Q4 2025 at Outset Medical, down from 0.59% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.29% in Q3 2021 to a low of 3.43% in Q4 2024.
- A 5-year average of 0.98% and a median of 0.61% in 2022 define the central range for Return on Equity.
- Peak YoY movement for Return on Equity: soared 1046bps in 2021, then tumbled -217bps in 2024.
- Outset Medical's Return on Equity stood at 0.34% in 2021, then plummeted by -84bps to 0.62% in 2022, then tumbled by -103bps to 1.26% in 2023, then plummeted by -173bps to 3.43% in 2024, then skyrocketed by 82bps to 0.61% in 2025.
- Per Business Quant, the three most recent readings for OM's Return on Equity are 0.61% (Q4 2025), 0.59% (Q3 2025), and 0.6% (Q2 2025).